Comparison

Evacetrapib (LY2484595) 50mg

Item no. A11397-50
Manufacturer Adooq
CASRN 1186486-62-3
Amount 50 mg
Quantity options 10 mg 100 mg 10mM x 1mL in DMSO 2 mg 25 mg 5 mg 50 mg
Category
Type Inhibitors
Specific against other
Purity >98%
Smiles CC1=CC(=C2C(=C1)[C@H](CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias LY2484595, LY-2484595, LY 2484595
Similar products Evacetrapib (LY2484595)
Available
Storage Conditions
2 years at -20C
Molecular Weight
638, 65
Chemical Name
trans-4-[[(5S)-5-[[[3, 5-Bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2, 3, 4, 5-tetrahydro-7, 9-dimethyl-1H-1-benzazepin-1-yl]methyl]cyclohexanecarboxylic acid
Description
Evacetrapib (LY2484595) is a drug that inhibits cholesterylester transfer protein, which transfers and thereby increases high-density lipoprotein and lowers low-density lipoprotein.
Solubilty
DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Delivery expected until 8/7/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close